国家: 台湾
语言: 中文
来源: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
OMEPRAZOLE
臺灣阿斯特捷利康股份有限公司 台北市大安區敦化南路二段207號21樓 (16440975)
A02BC01
凍晶注射劑
OMEPRAZOLE (5640002300) MG
小瓶;;安瓿
製 劑
限由醫師使用
ASTRAZENECA AB S-151 85 SODERTALJE SWEDEN SE
omeprazole
下列病症無法幾口服藥物有效治療時之取代療法:十二指腸潰瘍、胃潰瘍、逆流性食導炎及ZOLLINGER-ELLISON症。
註銷日期: 2016/08/19; 註銷理由: 自請註銷; 有效日期: 2018/05/04; 英文品名: LOSEC 40MG I.V. INJECTION
已註銷
1993-05-04
1 LOSEC 40 MG _omeprazole _ POWDER AND SOLVENT FOR SOLUTION FOR INJECTION COMPOSITION 1 vial containing dry substance and 1 ampoule containing solvent. The substance for injection contains: Omeprazole sodium equivalent to omeprazole 40 mg. For excipients see “List of excipients”. PHARMACEUTICAL FORM Powder and solvent for solution for injection THERAPEUTIC INDICATIONS Duodenal ulcer, gastric ulcer and reflux oesophagitis. Zollinger-Ellison syndrome. POSOLOGY AND METHOD OF ADMINISTRATION _Duodenal ulcer, gastric ulcer and reflux oesophagitis:_ Patients who cannot be given oral medication can be treated parenterally with 40 mg once daily. The usual treatment period before transfer to oral treatment is 2-3 days. In _Zollinger-Ellison syndrome_ the dose should be adjusted individually. Higher doses and/or several doses daily may be required. Intravenous treatment can be given as _injection_, whereby the solution for injection must be given slowly over a period of at least 2½ minutes and with a rate of maximum 4 ml per minute. _Impaired renal function _ A dose adjustment is not necessary for patients with impaired renal function. _Impaired liver function _ In patients with impaired liver function clearance is greatly reduced. _Elderly patients _ A dose adjustment is not necessary in elderly patients. _Children _ There is only limited experience of treatment in children. CONTRAINDICATIONS Known hypersensitivity to omeprazole, substituted benzimidazoles or any of the excipients. Omeprazole like other PPIs must not be used concomitantly with nelfinavir (see Interactions with other medicinal products and other forms of interaction). SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE In the presence of any alarm symptoms (eg, significant unintentional weight loss, recurrent vomiting, dysphagia, haematemesis or melena) and when gastric ulcer is 2 suspected or present, malignancy should be excluded, as treatment may alleviate symptoms and delay diagnosis. Co-administration of atazanavir with proton pump inhibitors is not 阅读完整的文件